Larimar Therapeutics, Inc.
METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND MITOCHONDRIA ASSOCIATED DISEASES

Last updated:

Abstract:

The present disclosure provides methods for treating or ameliorating a myelin associated disease or a mitochondria associated disease that comprising administering to a subject in need thereof a frataxin replacement therapeutic compound, e.g., a fusion protein comprising frataxin.

Status:
Application
Type:

Utility

Filling date:

30 Apr 2021

Issue date:

25 Nov 2021